Sec Form 4 Filing - F.C.P.R. Genavent @ SCYNEXIS INC - 2014-05-07

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person F.C.P.R. Genavent 2. Issuer Name and Ticker or Trading Symbol SCYNEXIS INC [ SCYX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 90 BOULEVARD PASTEUR, CS 21564 3. Date of Earliest Transaction (MM/DD/YY) 05/07/2014 (Street) PARIS CEDEX 15, I075730 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 05/07/2014 X 5,251 A $ 0.2 5,251 D Common Stock 05/07/2014 X 5,251 A $ 0.2 10,502 D Common Stock 05/07/2014 X 3,501 A $ 0.2 14,003 D Common Stock 05/07/2014 C 53,112 A 67,115 D Common Stock 05/07/2014 C 96,921 A 164,036 D Common Stock 05/07/2014 C 46,824 A 210,860 D Common Stock 05/07/2014 C 16,738 A 227,598 D Common Stock 05/07/2014 P 10,000 A $ 10 237,598 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Common Stock Warrant (right to buy) $ 0.2 05/07/2014 X 5,251 12/07/2011 12/06/2016 Common Stock 5,251 $ 0 0 D Common Stock Warrant (right to buy) $ 0.2 05/07/2014 X 5,251 05/15/2012 05/14/2017 Common Stock 5,251 $ 0 0 D Common Stock Warrant (right to buy) $ 0.2 05/07/2014 X 3,501 12/11/2013 12/10/2018 Common Stock 3,501 $ 0 0 D Series B Preferred Stock ( 1 ) 05/07/2014 C 188,679 ( 1 ) ( 1 ) Common Stock 53,112 $ 0 0 D Series C Preferred Stock ( 2 ) 05/07/2014 C 342,726 ( 2 ) ( 2 ) Common Stock 96,921 $ 0 0 D Series D-1 Preferred Stock ( 3 ) 05/07/2014 C 955,215 ( 3 ) ( 3 ) Common Stock 46,824 $ 0 0 D Series D-2 Preferred Stock ( 4 ) 05/07/2014 C 341,456 ( 4 ) ( 4 ) Common Stock 16,738 $ 0 0 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other F.C.P.R. Genavent 90 BOULEVARD PASTEUR CS 21564 PARIS CEDEX 15, I075730 X Signatures By: /s/ STANISLAS CUNY, Manager 05/08/2014 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Upon closing of the Issuer's initial public offering, each share of Series B Preferred Stock converted automatically into shares of common s tock of the Issuer on a 1-for-3.536 basis, and had no expiration date. ( 2 )Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-3.536 basis, and had no expiration date. ( 3 )Upon closing of the Issuer's initial public offering, each share of Series D-1 Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-20.4 basis, and had no expiration date. ( 4 )Upon closing of the Issuer's initial public offering, each share of Series D-2 Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-20.4 basis, and had no expiration date.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.